Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
Phone+1-408-7315000
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Affymetrix (NASDAQ:AFFX) Frequently Asked Questions
What is Affymetrix's stock symbol?
Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."
How were Affymetrix's earnings last quarter?
Affymetrix, Inc. (NASDAQ:AFFX) posted its quarterly earnings data on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.11 by $0.02. The scientific and technical instruments company earned $95.60 million during the quarter, compared to analysts' expectations of $93.29 million. During the same period last year, the business earned $0.09 EPS. View Affymetrix's Earnings History.
Has Affymetrix been receiving favorable news coverage?
News stories about AFFX stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Affymetrix earned a media sentiment score of 1.5 on InfoTrie's scale. They also assigned media coverage about the scientific and technical instruments company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Affymetrix?
Shares of AFFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymetrix's official website?
How can I contact Affymetrix?
Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.
MarketBeat Community Rating for Affymetrix (NASDAQ AFFX)
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe AFFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
